Miriam Echevarría Selected Research

N-trifluoroacetyladriamycin

1/2021

Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Miriam Echevarría Research Topics

Disease

6	Hypoxia (Hypoxemia) 10/2018 - 07/2004
4	Neuromyelitis Optica (Devic's Disease) 10/2021 - 07/2014
4	Neoplasms (Cancer) 01/2019 - 01/2011
3	Multiple Sclerosis 11/2019 - 07/2014
3	Parkinsonian Disorders (Parkinsonism) 11/2018 - 04/2006
3	Parkinson Disease (Parkinson's Disease) 11/2018 - 03/2013
2	Hydrocephalus (Hydrocephaly) 01/2022 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 07/2014
2	Optic Neuritis (Retrobulbar Neuritis) 07/2016 - 07/2014
2	Myelitis 07/2016 - 07/2014
1	Dementia (Dementias) 01/2021
1	Normal Pressure Hydrocephalus 01/2021
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2018
1	Demyelinating Diseases (Demyelinating Disease) 07/2016
1	Carcinoma (Carcinomatosis) 11/2014
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2014
1	Inflammation (Inflammations) 01/2014
1	Lung Neoplasms (Lung Cancer) 01/2011
1	Glioma (Gliomas) 01/2011

Drug/Important Bio-Agent (IBA)

5	Aquaporins (Water Channels)IBA 01/2022 - 06/2013
4	Proteins (Proteins, Gene)FDA Link 01/2015 - 01/2011
3	Immunoglobulin G (IgG)IBA 10/2021 - 07/2016
3	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2018 - 03/2013
2	Aquaporin 4IBA 01/2021 - 07/2014
2	Aquaporin 1IBA 01/2021 - 01/2019
2	AntibodiesIBA 11/2019 - 07/2014
2	Transcription Factors (Transcription Factor)IBA 01/2011 - 10/2007
2	cobaltous chloride (cobalt(II)chloride)IBA 01/2011 - 07/2004
2	Messenger RNA (mRNA)IBA 01/2011 - 07/2004
1	AutoantibodiesIBA 10/2021
1	Retinaldehyde (Retinal)IBA 10/2021
1	N-trifluoroacetyladriamycinIBA 01/2021
1	Myelin-Oligodendrocyte GlycoproteinIBA 11/2019
1	Aquaporin 3IBA 01/2019
1	Oxygen (Dioxygen)IBA 10/2018
1	ElementsIBA 01/2018
1	Octoxynol (Triton X 100)IBA 07/2016
1	Bromodeoxyuridine (BrdU)IBA 01/2016
1	Therapeutic UsesIBA 11/2014
1	dichloro(phenanthroline)gold(III)IBA 11/2014
1	Protein Isoforms (Isoforms)IBA 07/2014
1	Natalizumab (Tysabri)FDA Link 07/2014
1	enhanced green fluorescent proteinIBA 07/2014
1	LuciferasesIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	Carisoprodol (Soma)FDA LinkGeneric 04/2006
1	Phosphoglycerate Kinase (Kinase, Phosphoglycerate)IBA 07/2004
1	EnzymesIBA 07/2004
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 07/2004
1	oxalylglycineIBA 07/2004

Therapy/Procedure

1	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2013
1	Transplantation 03/2013
1	Aftercare (After-Treatment) 01/2011